Koers BioAlliance Pharma SA Euronext Paris
Aandelen
C4X
Farmaceutische producten
slotkoers
Andere beurzen
|
||
- EUR | - |
Omzet 2021 | 4,06 mln. 4,38 mln. | Omzet 2022 | 1,44 mln. 1,56 mln. | Marktkapitalisatie | 15,64 mln. 16,85 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2021 | -5 mln. -5,39 mln. | Nettowinst (verlies) 2022 | -19 mln. -20,48 mln. | EV/omzet 2021 | 7,53 x |
Nettoliquiditeiten 2021 | 7,95 mln. 8,57 mln. | Nettoliquiditeiten 2022 | 4,45 mln. 4,8 mln. | EV/omzet 2022 | 7,75 x |
K/w-verhouding 2021 |
-6
x | K/w-verhouding 2022 |
-0,76
x | Werknemers | - |
Dividendrendement 2021 * |
-
| Dividendrendement 2022 |
-
| Vrij verhandelbaar | 73,93% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Shefali Agarwal
CEO | Chief Executive Officer | 50 | 01-06-21 |
Ashish Gulati
CTO | Chief Tech/Sci/R&D Officer | - | - |
Julien Miara
BRD | Director/Board Member | - | 17-09-20 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Jacques Mallet
BRD | Director/Board Member | 64 | 14-10-21 |
Khalil Barrage
BRD | Director/Board Member | 59 | - |
Director/Board Member | 61 | 29-06-11 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+30,38% | 684 mld. | |
+29,16% | 568 mld. | |
-4,36% | 361 mld. | |
+19,30% | 329 mld. | |
+3,73% | 284 mld. | |
+16,81% | 240 mld. | |
+9,11% | 208 mld. | |
-7,77% | 200 mld. | |
+7,68% | 166 mld. |
- Beurs
- Aandelen
- Koers ALVIO
- Koers C4X